Navigation Links
PDI Announces Group DCA's Launch of eDetailing Across Apple® and Android™ Mobile Devices
Date:4/25/2011

PARSIPPANY, N.J., April 25, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Group DCA has expanded its proprietary DIAGRAM™ software platform to enable eDetail delivery on popular mobile devices including the iPad®, iPod touch® and iPhone®(1) and Android™(2)-based phones.

"With physicians adopting smartphones and other mobile devices even faster than the general population, we are moving quickly to meet their information demands across all key media," said Jo Ann Saitta, SVP of Information Technology for PDI. "This extension of eDetailing to mobile programs is consistent with our growth strategy and positions PDI and Group DCA well across a broad range of communications channels to deliver our clients' messages to healthcare professionals."

Noted Ron Scalici, Group DCA Chief Innovations Officer, "Not only can our clients now reach physicians via multiple devices, but they can be assured that our content will be innovative and tailored specifically to particular platforms, while remaining confident in our commitment to complying with the requirements and appropriate disclosure standards of The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA)."

Group DCA's eDetailing programs utilize its proprietary DIAGRAM™ software to create a customized, self-initiated experience for each participant based upon their attitudes, preferences and information needs. An integrated data warehouse and centralized content library allow for greater efficiency in content creation and dissemination, and easy adaption of approved marketing materials across multiple device platforms. These capabilities facilitate the development and execution of additional outreach efforts under a broader, multi-channel strategy that may include PDI's field sales representatives, teledetailing, email and direct marketing.

About PDI, Inc.

PDI, with its interactive digital agency Group DCA, is a leading provider of integrated multi-channel promotional outsource services to established and emerging health care companies. The company is dedicated to enhancing engagement with healthcare practitioners and optimizing commercial investments for its clients by providing strategic flexibility, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.

(1) Apple, iPad, iPod touch and iPhone are registered trademarks of Apple Inc.

(2) Android is a trademark of Google Inc.

www.pdi-inc.com


'/>"/>
SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
2. iMD Companies, Inc. Announces Expansion of OMI Operations
3. Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
4. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
5. Misonix Announces New Distribution Agreement for Colombia
6. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
7. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
8. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
9. China Shenghuo Announces New Chief Financial Officer
10. ULURU Inc. Announces Going Concern Qualification
11. Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... 2016 Open Access Journal ... Elsevier , a world-leading provider of ... announced the launch of Clinical Neurophysiology ... focuses on clinical practice issues in clinical neurophysiology. The ... normal values and didactic reviews. It is an official ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... (PRWEB) May ... three new members of its Advisory Board. Joining the Grow ... Kusch. “All three of them embody the mission of our organization ... very fortunate to have them as we continue to expand our ...
(Date:5/24/2016)... ... May 24, 2016 , ... A newly released report ... on their access to trusted resources, both in face-to-face interactions and online. In “Heard, ... Color,” researchers concluded that the creative use of mobile digital devices can be an ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... 2016 increased by 9.3 million people, or 10% over last year, according to ... people covered under group policies was comparatively stable, with a slight decrease in ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Controlling and maintaining ... with the launch of the Aquanta Water Heater Controller , a first-of-its-kind system ... or web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives ...
(Date:5/24/2016)... Angeles, California (PRWEB) , ... May 24, 2016 , ... ... $4,000, food, clothing, supplies and other necessities to Eunime Orphanage in Tijuana, Mexico on ... pizza and play games at Peter Piper Pizza. , More than 15 volunteers ...
Breaking Medicine News(10 mins):